‘Hybrid immunity’ is the term for immunity acquired from both prior infection and vaccination.
Academic rigour, journalistic flair
Articles on Coronavirus insights
Displaying 141 - 160 of 1079 articles
About two-thirds of generation Z seem to want a hybrid working pattern in the future.
Many people have been left with longer-term impairments to their sense of smell following COVID.
The proportion of children aged five to 11 in the UK who have been vaccinated against COVID remains quite low. Why?
Pfizer and Moderna have both recently reported results for their COVID-19 vaccines in the youngest children.
Some young adults are hanging onto COVID habits – but less so than older people.
A study of more than 28,000 UK adults has found that vaccination after having COVID is linked to a decrease in long COVID symptoms.
Scientists are working on intranasal COVID vaccines. Not only are these vaccines delivered differently – but they also target a different part of our immune system.
Despite being an excellent vaccine, the use of AstraZeneca in the UK has declined over the course of the COVID pandemic.
Many young people with long COVID won’t have experience of a long-term illness. Here’s what to keep in mind.
Even taking into account people who have had COVID but didn’t know it, there’s still likely to be a group of people who have never been infected.
After reporting zero COVID cases until now, North Korea is facing a rapidly-spreading outbreak of the omicron variant. Here’s how things could play out.
A new study looks at UK kids’ physical activity levels once COVID restrictions had begun to lift compared with before the pandemic.
From skin lesions to hearing loss, unusual symptoms can be troubling for COVID patients.
What can China do to resolve a crisis that threatens not only the health and security of its people and economy, but the future of Chinese Communist Party and its leader Xi Jinping?
Fertility rates declined among women of all ages in the UK at the start of the pandemic – but have been picking up again, particularly among older mothers.
The Valneva vaccine is the sixth COVID vaccine to be approved in the UK.
While COVID-19 hasn’t been ruled out as a potential cause, the leading contender is actually adenovirus, a common infection in children that can lead to hepatitis on rare occasions.
More than 1,000 cases of omicron XE have been detected in the UK so far. But we shouldn’t be seriously concerned at this stage.
Fourth doses are now being offered to vulnerable groups. But if you’re young and healthy, will you need one?
Supported by
Top contributors
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Professor of Public Health, University of Sheffield
-
Lecturer in Psychology, Swansea University
-
Professor in Biomedical Sciences, University of Manchester
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Associate Professor in Viral Immunology, University of Birmingham
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Research Fellow in Virology, University of Leeds
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Assistant Professor in Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Professor of Primary Care Health Sciences, University of Oxford
